INDIANAPOLIS, Jan 08, 2008 -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil)(1) for once daily use (2.5 mg and 5 ...
Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.
INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary ...
Cialis® (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union Milestone reflects Eli Lilly and Company's ...
Like Viagra, Stendra and Levitra, Cialis is highly effective as a treatment for ED. But no medication has a 100 percent success rate, and Cialis is no exception. Even after you take Cialis, you could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results